Form 4: Amphastar Pharmaceuticals CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, sold shares to cover tax liabilities related to vesting restricted stock units.
Summary
- On March 15, 2025, William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, sold 1,968 shares of common stock at $26.66 per share to cover tax obligations.
- Following this transaction, Peters directly owns 128,262 shares of Amphastar Pharmaceuticals.
- On March 17, 2025, Peters sold 3,004 shares of common stock at $27.69 per share for the same reason.
- Following this transaction, Peters directly owns 125,258 shares of Amphastar Pharmaceuticals.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing relates to routine stock sales for tax purposes. It doesn't indicate any fundamental change in the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of the company's financial health or future prospects.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price due to increased selling pressure.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Sale of 1,968 shares of common stock at $26.66 per share. |
| 03/17/2025 | Sale of 3,004 shares of common stock at $27.69 per share. |
| 03/18/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.